食道がん化学放射線療法後のsalvage手術
|
|
- こうしょ かたいわ
- 5 years ago
- Views:
Transcription
1
2
3
4 Daly JM, et al. J Am Coll Surg 2000;190:
5 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:
6 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:
7 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:
8 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:
9 Esophageal Cancer (PDQ ): Treatment Stage III Esophageal Cancer Treatment of stage III esophageal cancer may include the following: Surgery. Clinical trials of chemotherapy plus radiation therapy, with or without surgery. Clinical trials of new therapies used before or after surgery.
10 Esophageal Cancer (PDQ ): Treatment Stage III Esophageal Cancer Standard treatment options: Surgical resection of T3 lesions. Treatment options under clinical evaluation: Chemotherapy plus radiation therapy with or without subsequent surgery.[1,2] Information about ongoing clinical trials is available from the NCI Web site.
11
12 Comprehensive Registry of Esophageal Cancer
13 Comprehensive Registry of Esophageal Cancer in 2000
14
15
16
17 Stage II Stage III
18
19
20
21
22 Stage II, III: T
23
24 1?
25 EMR (T4) M1-org)
26 Number (n=259) Male : female 225 : 34 Age (mean+sd) ( ) Upper 39 Middle 141 Lower 79 Squamous 254 Adenocarcinoma 2 Others 3
27 ctnm staging Number (n=259) T1 147 T2 17 T3 95 N0 158 N1 101 Stage I 130 Stage II, III 101 Stage IV(Lym) 28 Stage IV(LYM): metastasis in cervical or celiac lymph node
28 Stage I CDDP 80mg/mm 2 5FU 800mg/mm 2 Radiation 2Gy x2
29 Stage II, III, IV(LYM) CDDP 40mg/mm 2 5FU 400mg/mm 2 Radiation 2Gy x 2 CDDP 80mg/mm 2 5FU 800mg/mm x 2 -
30 Survival rate Stage I (n=130) Stage II, III (n=101) Stage IV (Lym) (n=28) year Kaplan-Meier)
31 Stage I Surgery (n=72) Survival rate Chemoradiotherapy (n=130) year Kaplan-Meier)
32 Stage I Chemorad 130 CR % Rec(-) 88 68% Rec(+) 35 Salvage(+) 25 Esophagectomy: 6 Dissection 1 EMR: 18 Salvage(-) 10 Alive 74 Died 14 Alive 17 Died 8 Alive 0 Died 10 Non-CR 7 Chemorad: chemoradiotherapy, CR: complete response, Rec: recurrence, EMR: endoscopic mucosal resection Salvage(+) 5 Esophagectomy: 4 EMR: 1 Salvage(-) 2 Alive 3 Died 2 Alive 1 Died 1
33 Stage II, III Survival rate Surgery (n=350) Chemoradiotherapy (n=101) year Kaplan-Meier)
34 Stage IV(Lym) Survival rate year Surgery (n=97) Chemoradiotherapy (n=28) Kaplan-Meier)
35 1
36 JCOG9708 (phase II) Stage I (T1N0M0) (CDDP/5-FU)II T1N0M05FU CDDP JCOG 0502 (phase III) cstage I ct1n0m0
37 2?
38 Salvage Survival rate Stage I (n=130) Stage II, III (n=101) Stage IV (Lym) (n=28) year Kaplan-Meier)
39 Stage I Chemorad 130 CR % Rec(-) 88 68% Rec(+) 35 Salvage(+) 25 Esophagectomy: 6 Dissection 1 EMR: 18 Salvage(-) 10 Alive 74 Died 14 Alive 17 Died 8 Alive 0 Died 10 Non-CR 7 Chemorad: chemoradiotherapy, CR: complete response, Rec: recurrence, EMR: endoscopic mucosal resection Salvage(+) 5 Esophagectomy: 4 EMR: 1 Salvage(-) 2 Salvage(+) 30 Esophagectomy:10 Dissection 1 EMR: 19 Alive 3 Died 2 Alive 1 Died 1
40 Stage II, III Chemorad 101 CR 66 65% Non-CR 35 Chemorad: chemoradiotherapy, CR: complete response, Rec: recurrence, EMR: endoscopic mucosal resection Rec(-) 38 38% Rec(+) 27 Salvage(+) 13 Esophagectomy: 5 Dissection 1 EMR: 7 Salvage(-) 14 Salvage(+) 10 Esophagectomy: 8 Dissection 1 EMR: 1 Salvage(-) 25 Salvage(+) 23 Esophagectomy:13 Dissection 2 EMR: 8 Alive 33 Died 5 Alive 9 Died 4 Alive 2 Died 12 Alive 4 Died 6 Alive 1 Died 24
41 Stage IV(Lym) CR 9 Rec(-) 4 15% Alive 4 Died 0 32% Salvage(+) 0 Chemorad 28 Rec(+) 5 Salvage(-) 5 Alive 1 Died 4 Non-CR 19 Chemorad: chemoradiotherapy, CR: complete response, Rec: recurrence, EMR: endoscopic mucosal resection Salvage(+) 3 Esophagectomy: 3 Salvage(-) 16 Salvage(+) 3 Esophagectomy: 3 Alive 1 Died 2 Alive 0 Died 16
42 59 2 CRT CR- EMR Salvage Surgery
43 2 Salvage
44 Ishikura S, et al. J Clin Oncol 2003;21:
45 Ishikura S, et al. J Clin Oncol 2003;21:
46
47
48
49
50
51
52 3 Salvage Salvage
53 59 1 CR non-cr
54 Stage I Chemorad 130 CR % Rec(-) 88 68% Rec(+) 35 Salvage(+) 25 Esophagectomy: 6 Dissection 1 EMR: 18 Salvage(-) 10 Alive 74 Died 14 Alive 17 Died 8 Alive 0 Died 10 Non-CR 7 Chemorad: chemoradiotherapy, CR: complete response, Rec: recurrence, EMR: endoscopic mucosal resection Salvage(+) 5 Esophagectomy: 4 EMR: 1 Salvage(-) 2 Alive 3 Died 2 Alive 1 Died 1
55 Stage I Chemorad 130 CR % Rec(-) 88 68% Rec(+) 35 Salvage(-) :10 PUL 2 HEP: 2 PLE: 1 LYM: 3 PS: 1 Reject: 1 Non-CR 7 Chemorad: chemoradiotherapy, CR: complete response, Rec: recurrence Salvage(-) : 2 Complication: 1 Reject: 1
56 Stage II, III Chemorad 101 CR 66 65% Non-CR 35 Chemorad: chemoradiotherapy, CR: complete response, Rec: recurrence, EMR: endoscopic mucosal resection Rec(-) 38 38% Rec(+) 27 Salvage(+) 13 Esophagectomy: 5 Dissection 1 EMR: 7 Salvage(-) 14 Salvage(+) 10 Esophagectomy: 8 Dissection 1 EMR: 1 Salvage(-) 25 Alive 33 Died 5 Alive 9 Died 4 Alive 2 Died 12 Alive 4 Died 6 Alive 1 Died 24
57 Stage II, III CR 66 65% Rec(-) 38 38% Rec(+) 28 PUL: 3 BON: 2 LYM: 5 T4: 1 Reject: 4 Chemorad 101 Non-CR 35 Chemorad: chemoradiotherapy, CR: complete response, Rec: recurrence Salvage(-) : 15 Salvage(-) : 26 PUL: 2 HEP: 1 BON: 2 PLE: 2 KID: 1 T4: 3 PS: 6 Complication: 1 Reject: 8
58 3 Salvage Salvage
59 59 3 Stage II,IIISurgery vs CRT Stage II, III (CRT) -Surgery vs CRT - EMR Salvage Surgery
60 JCOG 9906 (phase II) Stage II,III II prospective Phase II Stage II,III +/-Salvage surgery
61 Surgeon A Surgeon B Surgeon C Non-Salvage Salvage 1 14(25%) 2
62 Salvage
63 Salvage surgery CRT Salvage surgery n=62
64 Salvage surgery CRT Salvage surgery n=62 n=4 T4: 2 LYM: 2 n=58
65 Salvage surgery CRT Salvage surgery n=62 n=58 n=4 T4: 2 LYM: 2 n=7 T4: 6 n=51 PUL: 1 PER: 1
66 Salvage (n=62) (n=185) R0 51 (82%) 171 (92%) R1, R2 7 (11%) 14 (8%) Probe 4 (6%)
67 Salvage Esophagectomy Radical R1, R2 Probe ct1 13 ct2 6 ct T4: 4 T4: 2 PER:1 Lym:1 ct T4: 2 T4: 1 PUL:1
68 Salvage
69 Salvage surgery CRT Salvage surgery
70 Salvage Salvage 60Gy
71 Salvage Salvage (n=58) Age mean SD Male : female 55 : 2 Tumor location Upper 13 (22%) Middle 26 (45%) Lower 19 (33%) ctnm stage Stage I 12 (21%) Stage II 16 (28%) Stage III 22 (38%) Stage IV 8 (14%)
72 Chemoradiotherapy Patients n=58) National Cancer Center Hospital 36 (62%) Other hospital 22 (38%) Radiation dose 60 Gy 55 (95%) 70 Gy 3 (5%) Chemotherapy Platinum+5FU 56 (97%) Platinum alone 2 (3%) Chemotherapy course 2 20 (34%) (57%) (9%)
73 Chemoradiotherapy Patients n=58) non-cr 34 (59%) Recurrence after CR 24 (41%) Duration after chemoradiotherapy 6 months 21 (36%) > 6 months 27 (47%) > 12 months 10 (17%)
74 Salvage Esophagectomy Salvage (n=58) (n=185) Right thoracotomy 54 (93%) 184 (99%) Left thoracotomy 1 (.5%) Transhiatal 4 (7%) 3-field 25 (43%) 169 (91%) others 33 (57%) 16 (9%)
75 Reconstruction Salvage (n=58) (n=185) 22 (38%) 161 (87%) 33 (57%) 22 (12%) 3 (5%) 2 (1%) 55 (95%) 163 (88%) 3 (5%) 22 (12%) 41 (71%) 175 (95%) 14 (24%) 9 (5%) 3 (5%) 1 (.5%)
76 Salvage (n=58) (n=185) 20 (34%) 51 (28%) 19 (33%) 34 (18%) 5 (9%) 7 (4%) 11 (19%) 21 (11%) (59%) 147 (80%) (30%) 32 (17%) 7 (12%) 6 (3%)
77 Salvage surgery CRT Salvage surgery n=58 n=7 Operative: 1 Hospital: 5 Salvage
78 Salvage
79 Salvage?
80 Salvage No.1 No.2 No.3 No.4 No.5 No.6 No.7 No.8 CV
81 Lateral longitudinal anastomosis Lateral longitudinal anastomosis
82 Salvage No.1 No.2 No.3 No.4 No.5
83 5 Salvage
84 Salvage surgery CRT Salvage surgery n=62 n=51 n=11 n=7 n=44
85 Salvage No.1 CO2 20M 14M No.2 CO2 21M 12M No.3 CO2 19M 12M
86 Salvage surgery CRT Salvage surgery n=62 n=51 n=11 n=7 n=3 n=44
87 Salvage surgery n=51 n=7 n=3 n=14 Local: 6 Lym: 5 Org: 3 n=44 Salvage
88 6 Salvage?
89 Without preoperative therapy (n=185) Survival rate Salvage esophagectomy (n=58) year Kaplan-Meier)
90 Salvage Survival rate Recurrence after CR (n=24) non-cr (n=34) year Kaplan-Meier)
91 Salvage Survival rate R0 (n=51) R1, R2 (n=7) year Kaplan-Meier)
92 Salvage Survival rate ct1 (n=13) ct2 (n=6) ct3 (n=35) ct4 (n=4) year Kaplan-Meier)
93 6 Salvage
94 Salvage surgery CRT Salvage surgery n=62 n=51 n=11 n=7 n=3 n=14 n=44
95 Salvage Salvage
96
97 Salvage Salvage
98
99 (
100 2003 4
101 QOL
橡
TP T-13i AST ALT ALP Y CTP LOH CHE CRP 8.7 id 0.4 mg/d 21 AWL 131U/L 257 LU/L 12 111/L 234 11J/L 344 IU/L 0.30 mid No K a BUN ORE UA 142 meq/1 4.3 meqa 108 meqa 15.8 met! 0.71 mg/di 5.0 mg/d CEA 5_5 n8/m1
More information日本消化器外科学会雑誌第30巻第3号
Key words : gastric cancer, progltostic factor. multivariate analysis Factors selected after Coffelation- after Stepwise rnitrally check check H o s t l A g e C O 2 S e x C O 3 Pre-op. compliation O Treatment
More informationuntitled
twatanab@oncoloplan.com http://www.oncoloplan.com I II - III IV Fig 3. Survival curves overall and according to response Bruzzi, P. et al. J Clin Oncol; 23:5117-5125 25 Copyright merican Society of Clinical
More informationVOL.48 NO.5 Key words: locally advanced esophageal cancer, multimodality therapy, neo- adjuvant chemoradiotherapy
VOL.48 NO.5 Key words: locally advanced esophageal cancer, multimodality therapy, neo- adjuvant chemoradiotherapy MAY 2000 VOL.48 NO.5 MAY 2000 Table 2. Adverse events Toxicity was defined according to
More informationuntitled
( ) - 1 - - 2 - 38% 26% A) Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma 124 (J Clin Oncol 7: 126-131, 1989) 124 95 29 II 1 2,000mg/m 2 x 4 8g/m
More information1_2.eps
第32回 日本頭頸部癌学会ランチョンセミナー6 Pre-Meeting Abstract FDG-PET の頭頸部癌における臨床的有用性 司会 長 放射線治療センター長 講演 1 耳鼻咽喉科 部長 講演 2 PETセンター長 岡村 光英 先生 日時 2008年6月13日 金 12:00 13:00 会場 ハイアットリージェンシー東京 共催 第32回 日本頭頸部癌学会 日本メジフィジックス株式会社 136-0075
More informationPROGNOSTIC FACTORS OF LATERAL WALL OROPHARYNGEAL SQUAMOUS CELL CARCINOMA TOMOHIKO NIGAURI, M.D., SHIN ETSU KAMATA, M.D., KAZUYOSHI KAWABATA, M.D. MUNE
PROGNOSTIC FACTORS OF LATERAL WALL OROPHARYNGEAL SQUAMOUS CELL CARCINOMA TOMOHIKO NIGAURI, M.D., SHIN ETSU KAMATA, M.D., KAZUYOSHI KAWABATA, M.D. MUNENAGA NAKAMIZO, M.D., KATSUFUMI HOKI, M.D., HIROKI MITANI,
More informationPowered by TCPDF (www.tcpdf.org) Title 食道癌治療のパラダイムシフト Sub Title Paradigm shift in treatment for esophageal cancer Author 安藤, 暢敏 (Ando, Nobutoshi) Publisher 慶應医学会 Publication year 2005 Jtitle 慶應医学 (Journal
More information日本消化器外科学会教育集会
Medical oncology T4N4M1 I 1T4 T4 T4 T4 1 T4 down-staging T4 40Gy 1 2820 R0 down-staging R0 2 T440Gy 20Gy 3 T460Gy 4 T4 down-staging T4 43 5 1511 R0 T4 1 T436Gy 6 30 18 R0 T4 1 11 3 R0 Salvage T4 Lerut
More informationGy - FP -FU mg/m Day -, CDDP: mg/m Day FP -FU mg/m Day -, CDDP: mg/m Day T N M Ⅲ. 結果 - cc - cc Tis: / T a: / T b: / T : / T : / T : / f-stage Stage =
原著論文 - 細谷好則 1), 宇井崇 1), 倉科憲太郎 1), 春田英律 1), 斉藤心 1), 瑞木亨 1), 俵藤正信 1), 佐藤貴一 2), 山本徳博 2), 菅野健太郎 2), 長瀬通隆 3), 藤井博文 3), 柴山千秋 4), 中澤聖則 4), 三澤和秀 5), 和田政彦 5), 布宮伸 5), 平林由広 6), 西野宏 7), 宮崎邦夫 8), 去川俊二 8), 福嶋敬宜 9),
More informationuntitled
19 CSPOR CRC/2009.8.8-9 2009 8 8 ( ) - CSPOR CRC SEMINAR- twatanab@oncoloplan.com http://www.oncoloplan.com - Toru Watanabe MD - 2 Phase I: Dose Finding trial Phase II : Efficacy and Safety trial Phase
More information日本消化器外科学会雑誌第23巻第2号
Key words: carcinoma of the pancreatic head, carcinoma of the periampullary region, operative results of the pancreatic duodenal carcinoma, mode of tumor spread of the pancreatic duodenal carcinoma, factors
More informationCHEMOTHERAPY APR. 1984
VOL.32 S-3 CHEMOTHERAPY dihydro-4-oxo-7-(1-piperazinyl)-1, 8-naphthyridine- CHEMOTHERAPY APR. 1984 VOL.32 S-3 CHEMOTHERAPY Table 1 Implantation rates and post- implantation survival rates in females mated
More information肺癌第42巻第6号
REPORT 99 78 5.9 n59 5 8. n5 5 6 c-stage 5 c-stage IAn687.5c-STAGE IBn665c-STAGE IIAn69 7.8c-STAGE IIBn793c-STAGE IIIAn3853.6c-STAGE IIIBn395 7.6c-STAGE IVn69.9 p-stage 5 p-stage IAn79.p-STAGE IBn88 6p-STAGE
More informationuntitled
260 250 200 150 10 100 50 0 1960 1965 1970 1975 1980 1985 1985 1995 2000 2005 25% 56% 66% 60% 90 80 70 60 50 40 30 20 10 0 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 4 1999 1990 2003 2005 2010 500,000 70,000 100,000
More information69 (877) pigeon chest, modified Ravitch operation, chest plastic surgery Robicsek classification
69 (877) pigeon chest, modified Ravitch operation, chest plastic surgery Robicsek classification 70 (878) Fig. 1 A and B, preoperative (correction) finding of anterior chest surface with an asymmetrical
More information32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ
29 1 31 40 2014 31 Bisphosphonate related osteonecrosis of jaw; BRONJ 2008 4 2012 3 36 98 8 11 19 BRONJ 0 13 2 5 3 1 1 0 BP 4 15 10 5 α-streptococcus 0 BRONJ BRONJ BP I Paget 1 409-3898 1110 2014 1 27
More information日本消化器外科学会雑誌第29巻第9号
Table 1 Oligonucleotide primers used for RT-PCR and internal probes used for Southern blot hybridization Cytokine Primer Sequence (5'-3') 5' 3' Internal probe s' 3' Internal probe 5' 3' Internal probe
More information51-3 ›Áfi¡†i85-95†j
Department of Gynecology, National Cancer Center Hospital NICHIDOKU-IHO Vol. 51 No. 3 85 95(2006) Nerve-sparing Radical Hysterectomy Tomoyasu Kato, M.D., Ph.D. Summary During nerve-sparing radical hysterectomy,
More informationスライド 1
QOL 1 Goldberg, JCO 22:23-30, 2004 N9741: Oxaliplatin in First Line (US) IR 200 mg/m 2 OX 85 mg/m 2 every 3 weeks Efficacy IFL FOLFOX4 > IFL IROX FOLFOX4 IROX OS TTP RR 15.0 mo 6.9 mo 31 % P=0.0001 P=0.0014
More informationCHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study VOL. 41 S 1 Table 2. Levels (Đg/ml or Đg/g) of S-1006 in serum, bile, and tissue (gallbladder) after oral administration
More informationプログラム テーマ 中咽頭 (13 : : 45) 1 13 : : 35 : CQ1 : HPV CQ2 : : : 40 : CQ3 : CQ4 : : : 45 : CQ5 :
会長挨拶 24 12 12 4 15 9 HPV 6 2018 1 8 1,124 CQ 7 HPV 3 CRT CQ 24 舘田勝 1 プログラム テーマ 中咽頭 (13 : 30-16 : 45) 1 13 : 30-14 : 35 : CQ1 : HPV 1. 2. 3. CQ2 : 4. 2 14 : 35-15 : 40 : CQ3 : 5. 6. CQ4 : 7. 8. 3 15 : 40-16
More informationANALYSIS OF RADIOTHERAPY FOR LUMBOSACRAL CARCINOMATOUS NEUROPATHY Masatoshi TANIGUCHI, Yuko KANEYASU, Kumiko KARASAWA, Noboru FUKUHARA Makiko TANAKA,
ANALYSIS OF RADIOTHERAPY FOR LUMBOSACRAL CARCINOMATOUS NEUROPATHY Masatoshi TANIGUCHI, Yuko KANEYASU, Kumiko KARASAWA, Noboru FUKUHARA Makiko TANAKA, Midori KITA-Okawa, Tomohiko OKAWA (Received 8 December
More information44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)
(1) I 44 II 45 III 47 IV 52 44 4 I (1) ( ) 1945 8 9 (10 15 ) ( 17 ) ( 3 1 ) (2) 45 II 1 (3) 511 ( 451 1 ) ( ) 365 1 2 512 1 2 365 1 2 363 2 ( ) 3 ( ) ( 451 2 ( 314 1 ) ( 339 1 4 ) 337 2 3 ) 363 (4) 46
More informationi ii i iii iv 1 3 3 10 14 17 17 18 22 23 28 29 31 36 37 39 40 43 48 59 70 75 75 77 90 95 102 107 109 110 118 125 128 130 132 134 48 43 43 51 52 61 61 64 62 124 70 58 3 10 17 29 78 82 85 102 95 109 iii
More informationuntitled
19 11 13 300 18 3 31 1300mg 4 6 C 15 H 22 FN 3 O 6 359.35 + -1-5--β-D--5--1,2--2- -4- 19 11 13 300 18 3 31 A B B A 30 1 2 21 7 1 1 1.31m 2 900mg 1.31m 2 1.64m 2 1,200mg 1.64m 2 1,500mg B 30 1 2 14 7 1
More information表 2 第 33 回日本外科学会 (1932 年 ) における瀬尾による食道癌宿題報告 ( 文献 8 より引用 ) 表 1 第 33 回日本外科学会 (1932 年 ) における瀬尾による食道癌宿題報告 ( 文献 8 より引用 ) 図 1 中山恒明先生による胸壁前食道胃吻合の図 ( 文献 10 より
食道癌治療の変遷 はじめに 50 2002 12 2007 食道外科の歴史 1913 13 1929 33 1932 12 50 95 1950 7 7 20 60 10 20 1960 45 表 2 第 33 回日本外科学会 (1932 年 ) における瀬尾による食道癌宿題報告 ( 文献 8 より引用 ) 表 1 第 33 回日本外科学会 (1932 年 ) における瀬尾による食道癌宿題報告 (
More informationArthroscopic Treatment for Painful Bennett Lesions of the Shoulder in Baseball Players by M. Yoneda and K. Hayashida Department of Orthopaedic Surgery
Arthroscopic Treatment for Painful Bennett Lesions of the Shoulder in Baseball Players by M. Yoneda and K. Hayashida Department of Orthopaedic Surgery, Osaka Kosei-Nenkin Hospital K. Izawa and S. Wakitani
More informationGynecologic Oncology Trial and Investigation Consortium GOTIC-002
Gynecologic Oncology Trial and Investigation Consortium GOTIC-002 3 8 ...2...2...2...2...3...4...4...5...9...9...9...9...9... 13... 13... 13... 13... 13... 13... 13... 14... 14... 15... 15... 15...
More informationⅡ Hb 4.1g/dl S LST G S ESD 10 S S 4 4 S D mL tub1 muc SS ly0 v0 PM0 DM0 N0 0/27 S tub1 tub2 SS
92 183 188 2016 1 1,2) 1) 1) 1) 1) 1) 3) 1) 2016 2 1 2016 3 11 84 S 2011 10 S 30 40 2 tub1 muc SS ly0 v0 PM0 DM0 N0 0/27 S 30 30 2 tub1 tub2 SS ly0 v0 PM0 DM0 N0 0/19 stage tub1 M ly0 v0 HM0 VM0 stage
More informationSekijuzi-27.indd
G-CSF 産生胃癌の既報告 38 例の解析 Key words G-CSF はじめに granulocyte-colony stimulating factor G-CSF Robinson G-CSF G-CSF Obara G-CSF G-CSF autocrine growth PubMED 方法 Morstyn G-CSF G-CSF G-CSF Shimamura G-CSF G-CSF.
More information8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio
7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine
More information生命倫理100_資料4-7
26 27 Single cell clones picked from swaps12p36 (18) Single cell clones picked from swaps12p18 (24) 1.3% (p0) 1.1% (p58) 28 29 Outline 30 31 32 33 34 Columbia, The New York Stem Cell Foundation Oocyte
More informationTable 2 Cases of Nail Deformity Associated with upward Distortion of Distal Soft Tissue No. Age Sex Affected RegionsDuration Results M Both grea
Table 2 Cases of Nail Deformity Associated with upward Distortion of Distal Soft Tissue No. Age Sex Affected RegionsDuration Results 1. 49 M Both great toes 2 years Cured after 4 months 2. 11 F Both great
More information耳鼻咽喉科の診療に関連した味覚障害
25 1 17 22, 2012 QOL Canal wall up Bell 17 25 1 (%) 100 ** P0.008 80 60 40 20 No recovery Complete recovery 0 2W 6M 0-20 years n=18 2W 6M 2W 6M 21-40 years n=15 41-60 years n=27 3 2 1 Noninfla COMChole
More informationQuality of Life of Outpatients Treated with Low Anterior Resection or Anterior Resection for Colorectal Cancer orrelation Between Dyschezia and Self-c
Quality of Life of Outpatients Treated with Low Anterior Resection or Anterior Resection for Colorectal Cancer orrelation Between Dyschezia and Self-completed QOL Questionnaire- Nami Imai *1, Yoshihiro
More informationuntitled
1988 2000 2002 2004 2006 2008 IFN Lamivudine Adefovir Entecavir 1 Total number 560 Sex (male/female) 424/136 Age (years)* 38 (15-68) Duration of treatment (weeks)* 26 (1-592) Follow-up time (years) 75(05-21
More information好酸球性副鼻腔炎:診断ガイドライン(JESREC Study)
118 728 2015 : : JESREC Study Japanese Epidemiological Survey of Refractory Eosinophilic Chronic Rhinosinusitis Study : JESREC Study CT NSAIDs CT : JESREC Study JESREC Study 118 729 ph CTMRI Caldwell Luc
More informationBLADDER PRESERVATION BY CHEMORADIOTHERAPY IN COMBINATION WITH RADICAL TUR-BT IN MUSCLE INVASIVE BLADDER CANCER Jun-Ichiro Ishiokal, Yukio Kageyama1, N
BLADDER PRESERVATION BY CHEMORADIOTHERAPY IN COMBINATION WITH RADICAL TUR-BT IN MUSCLE INVASIVE BLADDER CANCER Jun-Ichiro Ishiokal, Yukio Kageyama1, Nobutaka Ichiyanagil, Yoshihiro Saito2, Satoshi Nozu2,
More information_’£”R‡Ù‡©
29 31 38 2008 31 1) 2) 2) 3) 2) 1) 2008 302008 12 Activities of Daily Living ADL ADL 42 ADL ADL 1990 QOL Quality of Life QOL 1 QOL // 2 Activity of Daily Living ADL Performance Status PS ADL 3 1) 2) 3)
More informationTable 1 Laboratory findings on admission Figure 2. Clinical course after admission 1-a 1-b 1-c 3-a 3-b 3-c Figure 1. CT findings on first admission: S
FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF Vol. 32, pp. 105 110, 2004 FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF 1 1 1 1 1 1 1 1 2 2 1 1 16 4 13 72 CRP
More informationPsychosomatical study on five cases with oral cancer committing suicide Masatsugu Shimizu and Keiichiro Ono Abstract: The records of five oral cancer
Psychosomatical study on five cases with oral cancer committing suicide Masatsugu Shimizu and Keiichiro Ono Abstract: The records of five oral cancer cases that committed suicide were studied psychosomatically.
More information48-3 ‰{”R†i74-84†j
Metallic Stents in the Gastrointestinal Tract Shiro Miyayama, M.D., Tetsuya Komatsu, M.D., Keiichi Taki, M.D., Tetsuya Minami, M.D., Chiharu Ito, M.D., Rieko Shinmura, M.D., Shigeyuki Takamatsu, M.D.,
More informationFig. 3 59 years old, male. A case of common bile duct stone. Endoscopic picture shows that an ellipsoid stone exists in the common bile duct. Fig. 1 77 years old, female. A case of common bile duct stone.
More informationuntitled
47-54 2012 1 1 1 1 1 2 1 2 10 59 1 2 1 5 2 5 10 2 10 4 484 113 42 14 4 Key words Rheumatoid Arthritis Property of the Pain Daily Life Treatment Approaches Process of Acceptance Received June 23, 2011;
More information卵巣癌の治療
K-net:2008.7.17 85 90 8 10 20 (FIGO) a (FIGO) b (FIGO) c (FIGO) a (FIGO) b (FIGO) c (FIGO) (FIGO) (FIGO) Risk factors Preventive factors Risk factors 35 PCO, Preventive factors? Relative risk
More information原著・報告・記録(44行)/P134~147_報告 肝移植症例登録
134 Vol. 52, No. 23 Liver transplantation in Japan. Registry by the Japanese Liver Transplantation Society The Japanese Liver Transplantation Society Summary As of December 31, 2016, a total of 8,825 liver
More information20mg #tr#5*xlj lffin&+'.':, t) r+'z)vt '+D#J Centers for Medicare & Medicaid Sewices Garden AS et al. Preliminary results ofradiation Therapy Oncology Group 97-03: a randomized phase II trial of
More information3) Beresford SAA, Weiss NS, Voigt LF, et al: Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet 349: 458-461, 1997 4) Daly
More information1) University Group Diabetes Program: A study of hypoglycemic agents on vascular complica- in patients with adult-onset tions diabetes. I. Design, methods and baseline results. Diabetes 19 (suppl. 2):
More information明海大学歯学雑誌 40‐2☆/1.前川
J Meikai Dent Med 0, 7 79, 0 7 0 5 0 5 0 5. 0 5 8.5 5 7. Stage 8.0Stage 78.7Stage 5.Stage.8 Clinical Pathological Study of Malignant Neoplasm on 5 Cases in Our Department for past 0 years Katsuyuki INOUE,
More information- - - - - - - - - - - - - - - - - - - - - - - - - -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -2...2...3...4...4...4...5...6...7...8...
取 扱 説 明 書 - - - - - - - - - - - - - - - - - - - - - - - - - -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -2...2...3...4...4...4...5...6...7...8...9...11 - - - - - - - - - - - - - - - - -
More information特集・総説・報告(44行)/P045-055_報告 日本肝移植研究会
45 Liver Transplantation in Japan in 2006 Part 2 Registry by the The Summary Four thousand three hundred thirty liver transplants have been performed as of December 31, 2006 in 59 institutions in Japan.
More information九州大学学術情報リポジトリ Kyushu University Institutional Repository 高齢心疾患患者における運動機能と身体的フレイル評価の意義 内藤, 紘一九州大学大学院人間環境学府 京都橘大学健康科学部 熊谷, 秋三九州大学大学院人間環境学府 九州大学基幹教育院 九州大
九州大学学術情報リポジトリ Kyushu University Institutional Repository 高齢心疾患患者における運動機能と身体的フレイル評価の意義 内藤, 紘一九州大学大学院人間環境学府 京都橘大学健康科学部 熊谷, 秋三九州大学大学院人間環境学府 九州大学基幹教育院 九州大学キャンパスライフ 健康支援センター https://doi.org/10.15017/1800856
More informationi
14 i ii iii iv v vi 14 13 86 13 12 28 14 16 14 15 31 (1) 13 12 28 20 (2) (3) 2 (4) (5) 14 14 50 48 3 11 11 22 14 15 10 14 20 21 20 (1) 14 (2) 14 4 (3) (4) (5) 12 12 (6) 14 15 5 6 7 8 9 10 7
More information原 著 放射線皮膚炎に対する保湿クリームの効果 耳鼻科領域の頭頸部照射の患者に保湿クリームを使用して * 要旨 Gy Key words はじめに 1 70Gy 2 2 QOL
原 著 放射線皮膚炎に対する保湿クリームの効果 耳鼻科領域の頭頸部照射の患者に保湿クリームを使用して * 1 2 1 2 要旨 2011 1 2013 9 33 0 1 6 16 17 60Gy Key words はじめに 1 70Gy 2 2 QOL 3 4 2014 6 16 2015 4 17 連絡先 359 0042 3 2 Phone 04 2995 1511 Fax 04 2995 0633
More information05_学術.indd
Arts and Sciences IMRT Optimal bladder volume in IMRT planning for prostate cancer 36076 51710 55385 46169 29333 Key words: Prostate cancer, IMRT, 3D-CRT, Treatment planning, Bladder volume summary As
More information268 LSG 図 Lee ABCD 表 1 4 Age BMI C Duration Still DiaRem 表 1 4 HbA1c Ⅱ 対象と方法 1 17 LSG 6 3 Excess Weight Loss EWL BMI 25 kg/m 2 Hb
52 5 18 1 267 原著 ( 臨床研究 ) LSG ABCD DiaRem LSG 3 93.1 1 7.8 CR37.5 PR33.3 1 ABCD 5 DiaRem 12 LSG ABCD DiaRem LSG 腹腔鏡下スリーブ状胃切除術,ABCD スコア,DiaRem スコア Ⅰ はじめに Bariatric Surgery 2 1 metabolic surgery 2 ABCD 2
More information2 The Bulletin of Meiji University of Integrative Medicine 3, Yamashita 10 11
1-122013 1 2 1 2 20 2,000 2009 12 1 2 1,362 68.1 2009 1 1 9.5 1 2.2 3.6 0.82.9 1.0 0.2 2 4 3 1 2 4 3 Key words acupuncture and moxibustion Treatment with acupuncture, moxibustion and Anma-Massage-Shiatsu
More informationE3200 BV FOLFOX4 FOLFOX4 PFS % 0.42, 0.65 p< log-rank % FOLFOX4 8.6% FOLFOX % FOLFOX4 259/ % FOL
E3200 BV FOLFOX4 FOLFOX4 PFS 4.5 7.5 0.518 95% 0.42, 0.65 p
More informationuntitled
2303 16 2 9 1 14 5 31 (423) 1 (4), (6) C55H84ClN17O21S3 HCl (BLM-A2) 1487.47 11 2 1 4 104 2 14 5 31 [ ] ( ) ( ) 1. 15mg 30mg( ) 5 20mL 1 5mg( ) 2. 3 15mg 30mg( ) 5mL 1mg( ) 1mL 3. 5mg 15mg( ) 4. 1 2 1
More information03_学術.indd
Arts and Sciences CT Approach to the incidental discovery of early-stage breast cancer on a chest CT 33393 Key words: Breast cancer. CT. Mammography Abstract Recently, we have treated two patients in our
More information276-E12001.indd
2012; 54 (6): 276 285 91.6% 1 1 91.6% 2 142 54 196 (1) (2) 6 (3) (4) 60 1 54.2% 91.6% 1 6,226,192 8,418,514 65,945 300,898 ROI 933% 2012; 54 (6): 276 285 doi: 10.1539/sangyoeisei.E12001 1,2) 2) 3) 3 5)
More information第1部 一般的コメント
(( 2000 11 24 2003 12 31 3122 94 2332 508 26 a () () i ii iii iv (i) (ii) (i) (ii) (iii) (iv) (a) (b)(c)(d) a) / (i) (ii) (iii) (iv) 1996 7 1996 12
More informationFig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-
Fig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl) oxy]-14-ethyl-12,
More information脈管学55巻7号 pp.105-110
Online publication August 10, 2015 105 原 著 55 要 旨 : 18 29 31 27 87.1 EHIT class 1 class 2, 3 1 J Jpn Coll Angiol 2015; 55: 105 110 Key words: saphenous vein surgery, saphenous vein stump, endovenous heat-induced
More information1) Michaelis L. Biochem Z., 59, 78, 1914. 2) Ferris H. C. Dent. Cosmos Phila., 63, 10, 93, 1921. 3) Bloomfield A. L. Bull Johns Hopk. Hosp. Bait., 31, 118, 1920. 4) Starr H. C. J. Biol. Chem. Bait., 54,
More information_02戸沢.indd
Akita J Med 43 : 79-86, 2016 15 1 1 1 1 2 2 3 4 4 1 2 3 4 received 19 July 2016, accepted 29 July 2016 Two cases of histological CR for squamous cell lung cancer with invasion to the pulmonary artery after
More information表1票4.qx4
iii iv v 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 22 23 10 11 24 25 26 27 10 56 28 11 29 30 12 13 14 15 16 17 18 19 2010 2111 22 23 2412 2513 14 31 17 32 18 33 19 34 20 35 21 36 24 37 25 38 2614
More information第1章 国民年金における無年金
1 2 3 4 ILO ILO 5 i ii 6 7 8 9 10 ( ) 3 2 ( ) 3 2 2 2 11 20 60 12 1 2 3 4 5 6 7 8 9 10 11 12 13 13 14 15 16 17 14 15 8 16 2003 1 17 18 iii 19 iv 20 21 22 23 24 25 ,,, 26 27 28 29 30 (1) (2) (3) 31 1 20
More informationC/NC : committed/noncommitted
C/NC : committed/noncommitted 110 time post-icd implant 1) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report : Effect of encainaide and flecainide on mortality in a
More informationArthroscopic Subacromial Decompression for Impingement Syndrome by E. Shimozaki, K. Kitaoka, T. Matsumoto, H. Itokawa, T. Kobayashi and K. Tomita Depa
Arthroscopic Subacromial Decompression for Impingement Syndrome by E. Shimozaki, K. Kitaoka, T. Matsumoto, H. Itokawa, T. Kobayashi and K. Tomita Department of Orthopaedic Surgery, School of Medicine,
More information原著・報告・記録(44行)/P261~274_報告 肝移植症例登録
261 Liver Transplantation in Japan Registry by the Japanese Liver Transplantation Society The Japanese Liver Transplantation Society Summary As of December 31, 2013, a total of 7,474 liver transplants
More information原著・報告・記録(44行)/P156~169_報告 肝移植症例登録
156 Vol. 50, No. 23 Liver Transplantation in Japan Registry by the Japanese Liver Transplantation Society The Japanese Liver Transplantation Society Summary As of December 31, 2014, a total of 7,937 liver
More information特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)
VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.
More informationGroup5 tub1 CT ct4b cn1 ch0 cp0 cm0 cstage a D3 A V Type5 muc tub1 pt4b pn1 1/28 No. 201 pstage a UFT/UZEL 5
91 113 117 2015 1 2015 2 4 2015 2 23 73 3 Group5 tub1 CT ct4b cn1 ch0 cp0 cm0 cstage a D3 A V Type5 muc tub1 pt4b pn1 1/28 No. 201 pstage a UFT/UZEL 5 22 Key words: Ⅰ 0.2 1 0.01 2 1 D3 1 Ⅱ 73 2012 12 Takeshi
More information28 1 1a 1b 2 MRI T2 3 CT C3 N95 N95 6ml 90
2015 28 1 89 93 CT C3 Tb PCR XP WBC 7 600/mm 3 CRP 4 08mg/dl MRI MRI CT MRI WBC 9 700/mm 3 CRP 6 09mg/dl CT C3 C2 C7 low density area CT 89 28 1 1a 1b 2 MRI T2 3 CT C3 N95 N95 6ml 90 28 1 4 CT C2 C7 low
More information日本消化器外科学会雑誌第31巻第7号
Key words: obstructive jaundice, biliary drainage, bile refeeding, hepatectomy Fig. 1 Animal models a: experiment I b: experiment 2 silicon tube Fig. 2 Experimantal design Sham Ope J - l r bile duct Zweeks
More informationI? 3 1 3 1.1?................................. 3 1.2?............................... 3 1.3!................................... 3 2 4 2.1........................................ 4 2.2.......................................
More information20 15 14.6 15.3 14.9 15.7 16.0 15.7 13.4 14.5 13.7 14.2 10 10 13 16 19 22 1 70,000 60,000 50,000 40,000 30,000 20,000 10,000 0 2,500 59,862 56,384 2,000 42,662 44,211 40,639 37,323 1,500 33,408 34,472
More information- 2 -
- 2 - - 3 - (1) (2) (3) (1) - 4 - ~ - 5 - (2) - 6 - (1) (1) - 7 - - 8 - (i) (ii) (iii) (ii) (iii) (ii) 10 - 9 - (3) - 10 - (3) - 11 - - 12 - (1) - 13 - - 14 - (2) - 15 - - 16 - (3) - 17 - - 18 - (4) -
More information2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4 4 4 2 5 5 2 4 4 4 0 3 3 0 9 10 10 9 1 1
1 1979 6 24 3 4 4 4 4 3 4 4 2 3 4 4 6 0 0 6 2 4 4 4 3 0 0 3 3 3 4 3 2 4 3? 4 3 4 3 4 4 4 4 3 3 4 4 4 4 2 1 1 2 15 4 4 15 0 1 2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4
More information1 (1) (2)
1 2 (1) (2) (3) 3-78 - 1 (1) (2) - 79 - i) ii) iii) (3) (4) (5) (6) - 80 - (7) (8) (9) (10) 2 (1) (2) (3) (4) i) - 81 - ii) (a) (b) 3 (1) (2) - 82 - - 83 - - 84 - - 85 - - 86 - (1) (2) (3) (4) (5) (6)
More informationuntitled
1) American College of Surgeons:Advanced Trauma Life Support Course Manual. American College of Surgeons 1997;103-112 24 2) American Society of Anesthesiologists Task Force:Practice guideline for blood
More informationEVALUATION OF MAGNETIC RESONANCE IMAGING (MRI) IN DIAGNOSIS OF ACOUSTIC NEUROMA-COMPARATIVE STUDY WITH PLAIN X-RAY AND CTS- KIMIHISA NOMURA, M.D., MAK
EVALUATION OF MAGNETIC RESONANCE IMAGING (MRI) IN DIAGNOSIS OF ACOUSTIC NEUROMA-COMPARATIVE STUDY WITH PLAIN X-RAY AND CTS- KIMIHISA NOMURA, M.D., MAKOTO SAKAI, M.D., ATSUSHI SHINKAWA, M.D. and HIROSATO
More information日本職業・災害医学会会誌第51巻第5号
Reprint request: TREATMENT FOR CALCANEAL FRACTURE Yumiko ISHIBASHI, Hiroshi HIEDA, Katsuya KANESAKI, Takashi TAMAKI, Yoshimasa HIRAI, Tojiro YANAGI and Yoshifumi KUNO Department of Orthopedic Surgery,
More information1) Perissat J, Collet DR, Belliard R : Gallstones ; laparoscopic treatment, intracorporeal lithotripsy followed by cholecystotomy on cholecystectomy. Endoscopy 21 : 373-374, 1989 2) Kato K, Matsuda M,
More informationPowerPoint Presentation
Glioma 28% astrocytoma (WHO I) 0.28 anaplastic (WHO II/III) 0.18 Glioblastoma (WHO IV) 0.32 others 0.22 Meningioma partly malignant) 26% Pituitary adenoma 17% Neurinoma 11% Craniopharyngioma etc 5% Others
More informationクローン
..n 104 CD.. CD 105 CD CD 106 Heineke-Mikulicz Finney Jaboulay, 107 108 CD CD CD CD drainage seton seton 109 CD 110 , 111 CD vs 112 -ASA, mg/ mg/kg -MP mg/ -ASA X, kcal/ QOL 113 Crohn p - Cantor M, Bernstein
More informationTable 1. Numbers of Cancerous Pleurisy Cases According to Primary Site Table 2. Histological Type of Lung Carcinoma with Cancerous Pleurisy at Autopsy
Clinicopathological Studies on Cancerous Pleurisy, with Emphasis on Extra-Pulmonary Malignancy Table 1. Numbers of Cancerous Pleurisy Cases According to Primary Site Table 2. Histological Type of Lung
More information